The Law Offices of Frank R. Cruz continues its investigation of Zymergen Inc. (“Zymergen” or the “Company”) (NASDAQ: ZY) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On August 3, 2021, after the market closed, Zymergen issued a business update stating that it “recently became aware of issues with its commercial product pipeline that will impact the Company’s delivery timeline and revenue projections.” As a result, Zymergen “no longer expects product revenue in 2021, and expects product revenue to be immaterial in 2022.” The Company also announced that its Chief Executive Officer, Josh Hoffman, was stepping down, effective immediately.

On this news, the Company’s share price fell as much as 70% in afterhours trading on August 3, 2021, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Zymergen securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

View source version on businesswire.com: https://www.businesswire.com/news/home/20210804006042/en/

The Law Offices of Frank R. Cruz Continues Investigation of Zymergen Inc. (ZY) on Behalf of Investors